Progesterone and testosterone modulate the convulsant actions of pentylenetetrazol and strychnine in mice.
The influence of progesterone and testosterone on the incidence of seizures after administration of intraperitoneal pentylenetetrazol and subcutaneous strychnine was evaluated in mice. Pentylenetetrazol and strychnine were administered in doses that induced seizures in 40-50% of control mice in dioestrus (48 and 0.9 mg/kg, respectively). The percentage of seizures induced by pentylenetetrazol and strychnine was significantly lower in female mice in prooestrus/oestrus, when progesterone levels are high, than in dioestrus, when progesterone levels are low. Pretreatment of pentylenetetrazol-challenged mice with progesterone (250 microg/kg) increased the incidence of seizures in prooestrus/oestrus, without affecting seizures in dioestrus. The same pretreatment in strychnine-challenged mice also increased the incidence of seizures in prooestrus-dioestrus, but significantly reduced the incidence of seizures in dioestrus. In addition, progesterone pretreatment significantly increased the percentage of deaths induced by strychnine in prooestrus-oestrus, reducing deaths in dioestrus. Orchidectomized male mice had a significantly higher incidence of seizures after administration of pentylenetetrazol and strychnine than control mice. Administration of 11 daily doses of 250 microg/kg of testosterone to castrated mice significantly reduced the incidence of seizures induced by pentylenetetrazol. These results confirm the modulatory influence of reproductive steroids on the excitability of the central nervous system and the possible clinical importance of progesterone and testosterone in the management of partial epilepsy.
Pesce
M E
ME
Faculty of Medical Sciences, Pharmacology Program, University of Santiago de Chile.
Acevedo
X
X
Bustamante
D
D
Miranda
H E
HE
Pinardi
G
G
D000818:Animals; D003292:Convulsants / Q000037:antagonists & inhibitors / Q000633:toxicity*; D004031:Diestrus; D005260:Female; D012739:Gonadal Steroid Hormones / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D009919:Orchiectomy; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors / Q000633:toxicity*; D011374:Progesterone / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D012640:Seizures / Q000139:chemically induced* / Q000188:drug therapy* / Q000517:prevention & control; D013331:Strychnine / Q000037:antagonists & inhibitors / Q000633:toxicity*; D013739:Testosterone / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*
D003292:Convulsants; D012739:Gonadal Steroid Hormones; D013739:Testosterone; D011374:Progesterone; D013331:Strychnine; D010433:Pentylenetetrazole